Literature DB >> 33503230

The case against delaying SARS-CoV-2 mRNA vaccine boosting doses.

Paul Bieniasz1,2.   

Abstract

Entities:  

Year:  2021        PMID： 33503230     DOI： 10.1093/cid/ciab070

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

Review 1.  Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination.

Authors:  Sarah Cobey; Daniel B Larremore; Yonatan H Grad; Marc Lipsitch
Journal:  Nat Rev Immunol       Date:  2021-04-01       Impact factor: 108.555

2.  SARS-CoV-2 incidence and vaccine escape.

Authors:  Robin N Thompson; Edward M Hill; Julia R Gog
Journal:  Lancet Infect Dis       Date:  2021-04-13       Impact factor: 25.071

Review 3.  COVID-19 vaccination challenges: A mini-review.

Authors:  Zeinab Mohseni Afshar; Mohammad Barary; Rezvan Hosseinzadeh; Bardia Karim; Soheil Ebrahimpour; Kosar Nazary; Terence T Sio; Mark J M Sullman; Kristin Carson-Chahhoud; Emaduddin Moudi; Arefeh Babazadeh
Journal:  Hum Vaccin Immunother       Date:  2022-05-05       Impact factor: 4.526

4.  Impact of Previous Coronavirus Disease 2019 on Immune Response After a Single Dose of BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.

Authors:  María Velasco; Maria Isabel Galán; Maria Luisa Casas; Elia Pérez-Fernández; Diana Martínez-Ponce; Beatriz González-Piñeiro; Virgilio Castilla; Carlos Guijarro
Journal:  Open Forum Infect Dis       Date:  2021-06-04       Impact factor: 3.835

5.  Pandemic moves and countermoves: vaccines and viral variants.

Authors:  Rogier W Sanders; Menno D de Jong
Journal:  Lancet       Date:  2021-03-30       Impact factor: 79.321

Review 6.  SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact.

Authors:  Marc Lipsitch; Florian Krammer; Gili Regev-Yochay; Yaniv Lustig; Ran D Balicer
Journal:  Nat Rev Immunol       Date:  2021-12-07       Impact factor: 53.106
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.